[email protected] has a kind of interesting if kind of random article about biotech and the dynamics of innovation. It doesn't really make much of an argument either way, apart from noting that the pharma industry is in a bit of trouble, and that biotech is the light at the end of the tunnel.
So what else is new? The real problem is that very few people investing in biotech actually understand how radically different a game it is than tech.